Literature DB >> 22581301

Clinical perspective: statins and the liver--harmful or helpful?

James H Lewis1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22581301     DOI： 10.1007/s10620-012-2207-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  38 in total

1.  Yes! Statins can be given to liver patients.

Authors:  Ted Bader
Journal:  J Hepatol       Date:  2011-09-29       Impact factor: 25.083

2.  Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden.

Authors:  Einar Björnsson; Pernilla Jerlstad; Annika Bergqvist; Rolf Olsson
Journal:  Scand J Gastroenterol       Date:  2005-09       Impact factor: 2.423

3.  Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database.

Authors:  Ayse L Mindikoglu; Laurence S Magder; Arie Regev
Journal:  Liver Transpl       Date:  2009-07       Impact factor: 5.799

Review 4.  Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.

Authors:  Rossana M Calderon; Luigi X Cubeddu; Ronald B Goldberg; Eugene R Schiff
Journal:  Mayo Clin Proc       Date:  2010-04       Impact factor: 7.616

Review 5.  3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.

Authors:  Maria Tzefos; Jacqueline L Olin
Journal:  J Clin Lipidol       Date:  2011-06-28       Impact factor: 4.766

6.  Cerivastatin, genetic variants, and the risk of rhabdomyolysis.

Authors:  Kristin D Marciante; Jon P Durda; Susan R Heckbert; Thomas Lumley; Ken Rice; Barbara McKnight; Rheem A Totah; Bani Tamraz; Deanna L Kroetz; Hisayo Fukushima; Rüdiger Kaspera; Joshua C Bis; Nicole L Glazer; Guo Li; Thomas R Austin; Kent D Taylor; Jerome I Rotter; Cashell E Jaquish; Pui-Yan Kwok; Russell P Tracy; Bruce M Psaty
Journal:  Pharmacogenet Genomics       Date:  2011-05       Impact factor: 2.089

Review 7.  Risks associated with statin therapy: a systematic overview of randomized clinical trials.

Authors:  Amir Kashani; Christopher O Phillips; JoAnne M Foody; Yongfei Wang; Sandeep Mangalmurti; Dennis T Ko; Harlan M Krumholz
Journal:  Circulation       Date:  2006-12-11       Impact factor: 29.690

Review 8.  Statins and elevated liver tests: what's the fuss?

Authors:  Edward Onusko
Journal:  J Fam Pract       Date:  2008-07       Impact factor: 0.493

9.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

Review 10.  Statins and liver toxicity: a meta-analysis.

Authors:  Simon de Denus; Sarah A Spinler; Kristin Miller; Andrew M Peterson
Journal:  Pharmacotherapy       Date:  2004-05       Impact factor: 4.705
View more
  8 in total

1.  Effects of statins on the risk of hepatocellular carcinoma.

Authors:  Pejman G Mansourian; Masato Yoneda; M Krishna Rao; Fernando J Martinez; Emmanuel Thomas; Eugene R Schiff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-07

2.  Prescribing a statin to a cirrhotic patient to reduce hepatic decompensation and improve survival: impossible you say?

Authors:  James H Lewis
Journal:  Dig Dis Sci       Date:  2014-08       Impact factor: 3.199

Review 3.  Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.

Authors:  Jonathan G Stine; James H Lewis
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-12-25       Impact factor: 3.869

4.  Statin use in patients with cirrhosis: a retrospective cohort study.

Authors:  Sonal Kumar; Norman D Grace; Amir A Qamar
Journal:  Dig Dis Sci       Date:  2014-05-18       Impact factor: 3.199

Review 5.  Drug-induced liver injury: Do we know everything?

Authors:  Tamara Alempijevic; Simon Zec; Tomica Milosavljevic
Journal:  World J Hepatol       Date:  2017-04-08

Review 6.  Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.

Authors:  Philip Sarges; Joshua M Steinberg; James H Lewis
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.228

7.  Statin use and risk of liver cancer: an update meta-analysis.

Authors:  Meng Shi; Huiling Zheng; Biao Nie; Wei Gong; Xiaobing Cui
Journal:  BMJ Open       Date:  2014-09-16       Impact factor: 2.692

8.  Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice.

Authors:  Han Sol Park; Jung Eun Jang; Myoung Seok Ko; Sung Hoon Woo; Bum Joong Kim; Hyun Sik Kim; Hye Sun Park; In Sun Park; Eun Hee Koh; Ki Up Lee
Journal:  Diabetes Metab J       Date:  2016-04-21       Impact factor: 5.376
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.